A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.
about
Human papillomavirus and HPV vaccines: a reviewEarly Defensive Mechanisms against Human Papillomavirus InfectionEUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infectionThe potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study.Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples.Estimating progression rates for human papillomavirus infection from epidemiological data.Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunityPrevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer.Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.Vaccination with a human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in Korean girls aged 10-14 yearsHPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsyThe distribution of high-risk human papillomaviruses is different in young and old patients with cervical cancerHPV vaccine: an overview of immune response, clinical protection, and new approaches for the future.Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural EthiopiaDistribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South AfricaDetection of Human Papilloma Virus (HPV) in oral mucosa of women with cervical lesions and their relation to oral sex practices.Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions.Concurrence of multiple human papillomavirus infections in a large US population-based cohort.Human papilloma virus vaccination: impact and recommendations across the world.Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.HPV Reflex Testing in Menopausal Women.Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.A prospective study of age trends of high-risk human papillomavirus infection in rural China.Attitudes toward HPV Vaccination among Women Aged 27 to 45Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study.Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.[Efficacy of commercially available vaccines against HPV infection in women: a systematic review and meta-analysis].Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 yearsIncidence and clearance of genital human papillomavirus infection in men (HIM): a cohort studyThe Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance.High-risk HPV infection after five years in a population-based cohort of Chilean women.Alterations of T-cell surface markers in older women with persistent human papillomavirus infection.Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15-55 years and first-time modelling of antibody responses in mature women: results from an open-label 6-year follow-up study.Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
P2860
Q24657891-76B86E74-982E-446B-987A-5130A1E242F9Q26852611-649ADDC8-D886-428B-9D94-4ACAD9AC45A4Q27010432-4A4BD650-6060-42C0-9BB2-58E830B2D91CQ30251408-542C1FF5-2FAE-45F4-BA3A-903D2ED5C3C1Q30454956-4BFCE59C-A92D-4514-9A55-BBAF4A8BA163Q33321449-80088D64-3BDC-4A24-8217-A7375ADB7229Q33467330-F55EA923-C682-47C5-A88F-CCE9F39F6EC4Q33698774-C9D93327-8D44-4F5D-8BBE-F4911C25E149Q33797578-DE2591B6-F9A0-4CD1-AACC-FEBB2228B87FQ33803206-D8DCE1D2-D343-4BA3-8897-F7D9FEDA587EQ33833645-7E924156-9DD1-4EE8-B83F-BDE199F39218Q33863369-244FEA3C-BEDA-43F9-807B-7A5D660EFAD2Q34014798-2DF709CD-5348-4D20-B611-0CBA0927E7B9Q34048160-3FBB5B57-0F69-4469-95B7-9C1028570E1EQ34308427-E6A9D8FF-867D-4217-A7AD-0625C4B60605Q34335370-27185611-D27E-466A-935E-CCAB2DF59BC0Q34340212-30B148A8-5CFA-4B4F-954C-29C3651BD917Q34412349-DBEB225D-EBD3-41E3-82B5-FD73A9AD7F16Q34461458-C02D8937-D9B4-4FCA-8461-6695CFBB917DQ34477498-63170AFC-79C0-490B-8650-8A65E924F7E8Q34480019-745FA4C0-75CE-451E-A7D9-5616ABEE2922Q34553582-022DC055-BB38-4D50-8F96-7F266932F0DDQ34704575-753DCEBD-18EB-4BB3-B29C-BFEE90D1D2F5Q34763988-92D4AFCD-E8E0-411C-96D0-333395CDB52BQ34801294-485AEB0D-9C82-4885-AE8E-43555EA7DA0EQ34953464-50B2FF41-9B55-45B0-B545-6D296E633BB3Q35039759-7861F3CB-2B5E-47E3-9F0F-D954C1E6AF00Q35100159-CFE4E749-9D2A-48F1-89E0-49889D1F8EF0Q35101642-331443C8-71EB-4B44-A41F-2B639108F953Q35163993-C64CB97D-CA10-461C-9BEE-9F8257A987C6Q35220992-50F7798F-7254-4D14-B24F-428152AB25FBQ35427518-3D7EC5E4-2115-4D3E-8DCF-39AD58172232Q35577825-7E4F13F3-56F5-4584-8589-CB0E433F356BQ35596225-79319778-B759-4F25-81B1-0F16759097E0Q35619561-30250871-6656-4FB7-B6BE-2A3EF4523841Q35690441-EF1C74A2-94B8-48F4-834C-D314376E2854Q35721263-0C161AF5-9ABC-4B6E-A2D8-F87374626403Q35778017-D6A58365-0F34-4281-AD74-5EF04E9455DFQ35810353-337B2359-7A6B-4D9F-8D9D-DFBA6A5A72F5Q35937679-A65B8921-A765-4BFA-8DC5-38EC42AC232B
P2860
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@ast
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@en
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@nl
type
label
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@ast
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@en
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@nl
prefLabel
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@ast
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@en
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@nl
P2093
P50
P356
P1476
A prospective study of age tre ...... nce in Guanacaste, Costa Rica.
@en
P2093
M Concepcion Bratti
Mark E Sherman
Philip E Castle
Robert D Burk
Robert Tarone
Rolando Herrero
P304
P356
10.1086/428779
P407
P577
2005-05-02T00:00:00Z